Getinge AB (publ) (OTCMKTS:GNGBY – Get Free Report) shares passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $20.67 and traded as low as $18.43. Getinge AB (publ) shares last traded at $18.43, with a volume of 10,838 shares trading hands.
Getinge AB (publ) Price Performance
The company has a market capitalization of $4.78 billion, a price-to-earnings ratio of 22.91 and a beta of 0.82. The company has a current ratio of 1.67, a quick ratio of 0.98 and a debt-to-equity ratio of 0.20. The company has a 50 day moving average price of $20.60 and a 200 day moving average price of $19.35.
Getinge AB (publ) (OTCMKTS:GNGBY – Get Free Report) last announced its quarterly earnings data on Friday, October 18th. The company reported $0.21 EPS for the quarter. The firm had revenue of $755.49 million during the quarter. Getinge AB (publ) had a return on equity of 8.24% and a net margin of 5.04%.
About Getinge AB (publ)
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.
Read More
- Five stocks we like better than Getinge AB (publ)
- Breakout Stocks: What They Are and How to Identify Them
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- What is the FTSE 100 index?
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Compound Interest and Why It Matters When Investing
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Getinge AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.